Dooil Jeoung Selected Research

Dooil Jeoung Research Topics

Disease

43	Neoplasms (Cancer) 05/2022 - 04/2006
22	Inflammation (Inflammations) 01/2021 - 02/2008
19	Testicular Neoplasms (Testicular Cancer) 01/2021 - 04/2006
10	Leukemia 01/2021 - 02/2008
10	Melanoma (Melanoma, Malignant) 01/2021 - 01/2008
6	Atopic Dermatitis (Atopic Eczema) 01/2021 - 05/2008
6	Hypersensitivity (Allergy) 01/2021 - 02/2008
6	Anaphylaxis (Anaphylactic Shock) 01/2020 - 04/2011
6	Neoplasm Metastasis (Metastasis) 02/2017 - 01/2011
3	Stomach Neoplasms (Stomach Cancer) 01/2021 - 06/2006
3	Carcinogenesis 09/2019 - 03/2008
3	Lung Neoplasms (Lung Cancer) 09/2019 - 07/2007
2	Breast Neoplasms (Breast Cancer) 10/2020 - 07/2007
2	Prostatic Neoplasms (Prostate Cancer) 01/2017 - 01/2011
2	Hypoxia (Hypoxemia) 01/2017 - 12/2014
2	Atherosclerosis 03/2013 - 12/2008
2	Asthma (Bronchial Asthma) 04/2011 - 06/2009
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2020
1	Colorectal Neoplasms (Colorectal Cancer) 12/2019
1	Insect Bites and Stings (Insect Bite) 10/2019
1	Sarcoma (Soft Tissue Sarcoma) 09/2019
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 11/2018
1	Alzheimer Disease (Alzheimer's Disease) 10/2018
1	Huntington Disease (Huntington's Disease) 10/2018
1	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2018
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2018

Drug/Important Bio-Agent (IBA)

31	AntigensIBA 01/2021 - 04/2006
15	Pharmaceutical PreparationsIBA 01/2021 - 07/2009
12	Proteins (Proteins, Gene)FDA Link 01/2021 - 06/2006
11	MicroRNAs (MicroRNA)IBA 05/2022 - 10/2014
8	Peptides (Polypeptides)IBA 01/2018 - 04/2006
6	Histones (Histone)IBA 01/2020 - 11/2008
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2019 - 12/2013
6	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2013 - 08/2006
5	histone deacetylase 3IBA 12/2018 - 07/2012
5	CytokinesIBA 01/2018 - 06/2009
5	IntegrinsIBA 01/2017 - 01/2011
5	celastrolIBA 08/2015 - 06/2009
5	NF-kappa B (NF-kB)IBA 02/2010 - 01/2008
4	Paclitaxel (Taxol)FDA LinkGeneric 11/2018 - 10/2014
4	Anti-Allergic Agents (Antiallergic Agents)IBA 09/2017 - 02/2008
4	Protein Glutamine gamma Glutamyltransferase 2IBA 10/2014 - 08/2006
4	Phosphotransferases (Kinase)IBA 11/2009 - 02/2008
4	Complementary DNA (cDNA)IBA 11/2008 - 04/2004
3	Histone Deacetylases (Histone Deacetylase)IBA 01/2021 - 10/2014
3	DinitrofluorobenzeneIBA 01/2020 - 05/2008
3	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 01/2013
3	Immunoglobulin E (IgE)IBA 10/2019 - 04/2011
3	Hyaluronic Acid (Hyaluronan)IBA 08/2008 - 01/2008
2	dinitrophenyl-human serum albumin conjugateIBA 01/2021 - 01/2020
2	LigandsIBA 10/2020 - 01/2018
2	Histone Deacetylase InhibitorsIBA 01/2020 - 10/2019
2	Mitogen-Activated Protein KinasesIBA 01/2020 - 09/2019
2	TOR Serine-Threonine KinasesIBA 01/2020 - 09/2019
2	Irinotecan (Camptosar)FDA LinkGeneric 12/2019 - 02/2017
2	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 12/2019 - 02/2017
2	arginyl-leucyl-tyrosyl-glutamic acidIBA 12/2019 - 02/2017
2	AllergensIBA 10/2019 - 06/2009
2	ErbB Receptors (EGF Receptor)IBA 09/2019 - 04/2011
2	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 09/2019 - 01/2007
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 09/2019 - 01/2010
2	Cisplatin (Platino)FDA LinkGeneric 11/2018 - 07/2007
2	Conditioned Culture MediaIBA 01/2018 - 04/2014
2	ChemokinesIBA 01/2018 - 05/2015
2	Transcription Factors (Transcription Factor)IBA 01/2018 - 05/2014
2	Hexosaminidases (Hexosaminidase)IBA 01/2018 - 10/2014
2	Fibronectins (Fibronectin)IBA 01/2017 - 01/2011
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2017 - 01/2013
2	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 01/2017 - 05/2014
2	Heme Oxygenase-1IBA 01/2017 - 12/2014
2	Small Interfering RNA (siRNA)IBA 01/2017 - 08/2012
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017 - 06/2009
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2017 - 05/2014
2	AntioxidantsIBA 03/2013 - 08/2012
2	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 08/2012 - 01/2010
2	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 08/2012 - 01/2010
2	CystamineIBA 02/2010 - 01/2008
2	Tetradecanoylphorbol AcetateIBA 02/2010 - 06/2009
2	p38 Mitogen-Activated Protein KinasesIBA 01/2010 - 06/2006
2	Matrix Metalloproteinase 2 (Gelatinase A)IBA 11/2009 - 07/2009
2	AutoantibodiesIBA 04/2004 - 02/2004
1	Interleukin-27 (Interleukin 27)IBA 01/2021
1	Sirtuin 1IBA 01/2021
1	Epidermal Growth Factor (EGF)IBA 10/2020
1	Immune Checkpoint InhibitorsIBA 01/2020
1	Immune Checkpoint ProteinsIBA 01/2020
1	Proto-Oncogene Proteins B-rafIBA 01/2020
1	Serum AlbuminIBA 01/2020
1	HomoharringtonineIBA 01/2020
1	Therapeutic UsesIBA 12/2019
1	IgE Receptors (Fc epsilon RI)IBA 10/2019
1	Tyrosine Kinase InhibitorsIBA 09/2019
1	AntibodiesIBA 09/2019
1	Phosphatidylinositols (Phosphatidylinositol)IBA 09/2019
1	Beclin-1IBA 01/2018
1	Interleukin-5 (Interleukin 5)IBA 01/2018
1	Interleukin-17 (Interleukin 17)IBA 01/2018
1	Histamine (Histamine Dihydrochloride)FDA Link 01/2018
1	Chemokine CXCL2IBA 01/2018

Therapy/Procedure

10	Therapeutics 05/2022 - 06/2007